Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04526704
Title Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib (PLX3397)
Acronym PLX3397
Recruitment Completed
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Daiichi Sankyo, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | HUN | ESP | AUS

Facility Status City State Zip Country Details
Honor Health Scottsdale Arizona 85258 United States Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
Chris O'Brien Lifehouse Camperdown New South Wales 2050 Australia Details
Peter MacCallum Cancer Centre East Melbourne Victoria 3000 Australia Details
Magyar Honvedseg Egeszsegugyi Kozpont Budapest H-1062 Hungary Details
Rizzoli-Istituto Ortopedico Rizzoli Bologna 40136 Italy Details
Fondazione IRCC Istituto Nazionale dei Tumori Milano 20133 Italy Details
Leiden University Medical Center (LUMC) Leiden 2333 ZA Netherlands Details
Hospital Sant Pau Barcelona 08041 Spain Details
Hospital Virgen del Rocio Sevilla 41013 Spain Details
National Taiwan University Hospital Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field